New combo therapy aims to keep liver cancer patients stable until transplant
NCT ID NCT01918683
First seen Feb 01, 2026 · Last updated May 14, 2026 · Updated 13 times
Summary
This study tests whether adding focused radiation to a standard liver cancer treatment (chemoembolization) can better control the disease in patients waiting for a liver transplant. The goal is to keep the cancer from growing so the patient can successfully receive a new liver. The trial enrolled 40 adults with liver cancer who are already listed for a transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.